Local News: Grande Prairie, AB 

 | 

Sign Up

 | 

Sign In

Advertisment

Ranbaxy Laboratories

Ranbaxy Laboratories News Editors

RoboBlogger

I edit this news page on Topix when no humans are available to help.

People just like you make Ranbaxy Laboratories News on Topix better every day. If you're interested in becoming an editor, apply today!

Edits History | Editor Blog

RSS icon mobile icon

Ranbaxy Laboratories News

News on Ranbaxy Laboratories continually updated from thousands of sources around the net.

Monday Nov 9 | Mydigitalfc.com

Issues with USFDA to take long to resolve: Ranbaxy

Drug Administration to sort out issues related to generic drugs but the matter is likely to take long to resolve.

Comment?

Related Topix: Biotech, World News, India,

Mon Oct 26, 2009

The Hindu

Ranbaxy back in black

NEW DELHI: Riding on the back of consistent sales in emerging markets and cost cutting measures, Ranbaxy Laboratories on Monday posted a consolidated profit after tax of Rs.

Comment?

Related Topix: Ranbaxy Laboratories, Biotech, Healthcare Industry

Fri Oct 23, 2009

Express India

Badal asks Ranbaxy to add booster dose to state healthcare

Chandigarh: Punjab chief minister Parkash Singh Badal has asked Ranbaxy Laboratories Limited to prepare a comprehensive plan to undertake extensive research to study the root cause of the deadly diseases and suggest measures for their effective eradication to make Punjab, a disease-free state.

Comment?

Related Topix: Biotech

Fri Oct 09, 2009

Canada.com

Pfizer may make counter bid for Ranbaxy

Pfizer may bid for Ranbaxy Laboratories, countering a $4.6 billion offer by Japan's Daiichi Sankyo for the Indian generic drug maker, the Business Standard newspaper said.

Comment?

Related Topix: Biotech, Ranbaxy Laboratories, Healthcare Industry

Wed Oct 07, 2009

Expressindia

EU anti-trust raid on Ranbaxy France unit

New Delhi After facing a slew of troubles in the US market last year, the country's largest drug maker, Ranbaxy Laboratories Ltd, in which Daiichi Sankyo of Japan has a 64% stake, is in for some rude shock in Europe.

Comment?

Related Topix: World News, India, Biotech, Asia

Tue Oct 06, 2009

Express India

Ranbaxy to market Daiichi's products in Mexico

The Gurgaon-based drug firm would market the products through its Latin America-based subsidiary, Ranbaxy Mexico SA de CV Mexico.

Comment?

Related Topix: World News, India, Biotech,

Sat Sep 19, 2009

The Hindu

Ranbaxy to market Medy-Tox product

GURGAON: Ranbaxy Laboratories has entered into an in-licensing agreement with Medy-Tox, South Korea's Botulinum-Toxin specialised biotech venture, for the latter's cosmetic product, Neuronox.

Comment?

Related Topix: Ranbaxy Laboratories, Biotech, Healthcare Industry

Thu Sep 17, 2009

Mydigitalfc.com

Ranbaxy ties up with South Korean firm

Drug major Ranbaxy Laboratories has entered into a deal with South Korean biotech firm Medy-Tox for marketing its cosmetic product, Neuronox, in the Indian market.

Comment?

Related Topix: Biotech, Marketing

Tue Sep 01, 2009

Med Ad News

Daiichi Sankyo and Ranbaxy Leverage New Business Model with Launch of Evista in Romania

TOKYO, Gurgaon, India, September 1, 2009 - Daiichi Sankyo Company Limited and Ranbaxy Laboratories Limited announced today that Terapia S.A. , a subsidiary of Ranbaxy in Romania, will market the osteoporosis medication, Evista in Romania.

Comment?

Related Topix: Medicine, Evista, Raloxifene (generic), Medication, World News, India, Biotech, Osteoporosis, Health, Marketing

Wed Aug 12, 2009

Hindustan Times

Flu vaccine flies off the shelves

With the government indicating on Monday that it would soon procure 20 million capsules of the generic antiviral drug Tamiflu in the wake of the spread of swine flu, drug makers across the country including Ranbaxy, Cipla, Hetero and Roche are bracing themselves for a hike in production of the in-demand drug.

Comment?

Related Topix: Tamiflu, Oseltamivir (generic), Medicine, Medication, Influenza, Health, H1N1 Influenza / Swine Flu, Biotech, Ranbaxy Laboratories, Healthcare Industry

Domain-B

Swine flu bolsters Indian pharma stocks

Shares of Indian drug firms that make the generic version of Roche's Tamiflu, used to treat H1N1 flu, rose 5-19 per cent on Tuesday as the death toll from the pandemic in the country rose to ten.

Comment?

Related Topix: H1N1 Influenza / Swine Flu, Financial Markets, Tamiflu, Oseltamivir (generic), Medicine, Medication, Epidemic, Natural Disasters, Biotech

Fri Jul 24, 2009

The Age

India's Ranbaxy's Q2 profit soars but sees year loss

Top Indian generic drugs firm Ranbaxy Laboratories, a unit of Japan's Daiichi Sankyo, reported Friday net profit soared during the second quarter, swelled by foreign exchange gains.

Comment?

Related Topix: Biotech, World News, India, Food and Drug Administration

Tue Jul 21, 2009

Domain-B

Ranbaxy to market cholesterol-lowering drug in Canada

Ranbaxy Laboratories has received a final approval from from Health Canada, therapeutic products directorate to manufacture and market Ran-Simvastatin tablets in Canada.

Comment?

Related Topix: Biotech, Medicine, Ranbaxy Laboratories, Cholesterol, Healthcare Industry, Zocor, Simvastatin (generic), Medication

Mon Jun 01, 2009

The Telegraph

Dr Reddy's eyes prime position in US generics

Mumbai, May 31: Hyderabad-based Dr Reddy's Laboratories Ltd aims to be among the top five generic companies in the US by 2013, banking on an array of new drugs for which it is seeking permissions from American authorities.

Comment?

Related Topix: Biotech, Medicine, Dr Reddys Laboratories, Healthcare Industry, Ranbaxy Laboratories

Sat May 30, 2009

Bloomberg.com - Asia

Ranbaxy Chief Executive Singh Steps Down in Daiichi Sankyo Turnaround Plan

Ranbaxy Laboratories Ltd. , heading for an annual loss and battling a U.S. ban on some of its drugs, said Chief Executive Officer Malvinder Singh quit as head of the company his family controlled for more than half a century.

Comment?

Related Topix: Biotech, World News, India,

Thu May 28, 2009

PharmaExec.com

Ranbaxy chief steps down

Chairman and chief executive of Ranbaxy Laboratories, Malvinder Singh, has stepped down, handing more control over the generic drug maker to its Japanese owner Daiichi Sankyo.

Comment?

Related Topix: Biotech

Bloomberg

FDA Is Reviewing Ranbaxy's Corrective Action Plan on Drug Exports to U.S.

The U.S. drug regulator is reviewing a a oecorrective actiona plan from Indiaa s Ranbaxy Laboratories Ltd.

Comment?

Related Topix: Food and Drug Administration, Biotech

Tue May 26, 2009

NewsTarget.com

Generic Drug Plant Caught Falsifying Data

The FDA has ordered a halt to approvals of drugs relying on data from a generic drug factory in India that was found to be falsifying data.

Comment?

Related Topix: Biotech, Ranbaxy Laboratories, Healthcare Industry, World News, India, Medicine, Medication, Pravachol, Pravastatin (generic)

Sun May 24, 2009

Earth Times

Daiichi Sankyo and Ranbaxy Announce Reconstitution of Ranbaxy Executive Leadership

TOKYO & GURGAON, India - Daiichi Sankyo Co., Ltd. and Ranbaxy Laboratories Limited today announced that Mr.

Comment?

Related Topix: World News, India, Biotech

Tue May 19, 2009

The Hindu

Rising rupee could help Ranbaxy negate loss in Q2

New Delhi : The appreciating Indian rupee against the US dollar could help drugmaker Ranbaxy Laboratories to make forex gains of up to $300 million in the current quarter, thus helping it to come out of red.

Comment?

Related Topix: World News, India, Biotech, Ranbaxy Laboratories, Healthcare Industry

Also on Topix